John P. Kenny - 15 Nov 2021 Form 4 Insider Report for MERIDIAN BIOSCIENCE INC

Role
Chief Executive Officer, Director
Signature
/s/ Bryan T. Baldasare as Attorney-in-fact for John P. Kenny
Issuer symbol
N/A
Transactions as of
15 Nov 2021
Net transactions value
$0
Form type
4
Filing time
16 Nov 2021, 14:56:16 UTC
Previous filing
08 Nov 2021
Next filing
24 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIVO Common Stock Other -155,511 -59% 109,620 15 Nov 2021 Direct F1
transaction VIVO Common Stock Award +155,511 +142% 265,131 15 Nov 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted share units granted pursuant to 2012 Stock Incentive Plan rescinded by the Issuer.
F2 Restricted share units granted pursuant to 2021 Omnibus Award Plan scheduled to vest as follows: (i) 99,505 on October 1, 2022; and (ii) 56,006 on November 15, 2023.